Apple and Pepsi pop on earnings, Puma skyrockets on cancer drug success

Time for your daily dose of trending tickers, the stocks that you're tracking as measured by Yahoo finance ticker searches. Making the list today:

We don't have Coke. Is Pepsi (PEP) OK? That's the word from Wall Street as the world's also-ran soda maker beat earnings estimates a day after rival Coke (KO) disappointed. Shares are bubbling higher by 3%. The trick was chips as Doritos and Lays grew 2.5% in North America, offsetting weakness in soda. Strength in Tropicana juices also helped the company earn $1.32 in earnings for the quarter.

Next up, Puma Biotechnology (PBYI). The stock rocketing up more than 275% today. The company announced last night that they had some very promising results in trials of a new breast cancer drug called Neratinib. According to the company the drug improved disease free survival rates by 33% compared to a placebo. Puma says they will apply for marketing approval for the drug early next year.

Finally, Apple (AAPL) is up 3% and making 52-week highs after reporting a quarter that was actually pretty bland, if we're being honest. Investors were encouraged by strong margins but iPad sales were a slight disappointment. Analysts and the iPublic are still waiting for release dates for the iPhone 6 and so-called phablet expected in September at the earliest. Nit-picking aside, Apple is so good the company almost needs a different set of metrics. Take cash on the balance sheet; after all the buybacks, dividends and the $3 Beats purchase Apple STILL has nearly $140 billion in net cash on the balance sheet. For those watching at home Apple's all-time high share price is $100.28, adjusted for its 7:1 split.

Those are your Trending Tickers today. Tell us what stocks you're watching on Twitter using the hashtag #TrendingTickers.

More from Yahoo Finance:
Yahoo Finance contributor Carl Icahn joins Tumblr
Dicks fires golf pros as thrifty consumers curtail spending
Dow poised to drop 3,000 points

Rates

View Comments (4)